XSUS:CA:TSX-iShares ESG MSCI USA Index (CAD)

ETF | US Equity |

Last Closing

CAD 38.38

Change

+0.89 (+2.37)%

Market Cap

CAD 0.58B

Volume

2.47K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-22 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

+3.03 (+2.39%)

CAD 21.09B
ZSP:CA BMO S&P 500

+1.88 (+2.41%)

CAD 17.10B
XSP:CA iShares Core S&P 500 (CAD Hedg..

+1.29 (+2.41%)

CAD 11.46B
VUN:CA Vanguard US Total Market

+2.35 (+2.47%)

CAD 10.87B
XUS:CA iShares Core S&P 500 Index ETF

+1.07 (+2.41%)

CAD 8.70B
HXS:CA Global X S&P 500 Corporate Cla..

+1.82 (+2.48%)

CAD 4.34B
VSP:CA Vanguard S&P 500 CAD hedged

+2.04 (+2.45%)

CAD 4.04B
QUU:CA Mackenzie US Large Cap Equity ..

+5.07 (+2.47%)

CAD 3.60B
XUU:CA iShares Core S&P US Total Mark..

+1.27 (+2.42%)

CAD 3.34B
ZUE:CA BMO S&P 500 (CAD Hedged)

+1.66 (+2.34%)

CAD 3.23B

ETFs Containing XSUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -14.54% 9% A- 18% F
Dividend Return 0.20% 17% F 6% D-
Total Return -14.34% 9% A- 18% F
Trailing 12 Months  
Capital Gain 4.66% 59% D- 55% F
Dividend Return 1.04% 26% F 17% F
Total Return 5.71% 54% F 47% F
Trailing 5 Years  
Capital Gain 80.27% 72% C 73% C
Dividend Return 7.46% 24% F 10% F
Total Return 87.73% 64% D 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 14.50% 76% C+ 80% B-
Dividend Return 15.42% 75% C 78% C+
Total Return 0.92% 34% F 36% F
Risk Return Profile  
Volatility (Standard Deviation) 15.12% 37% F 54% F
Risk Adjusted Return 101.99% 61% D- 93% A
Market Capitalization 0.58B 53% F 62% D

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.